JD Health(京东健康)
Fast facts
- Year Founded
- 2019
Source: Beijing Newswww.bjnews.com.cn/finance/2019/07/18/604808.html
- HQ Location
- Beijing, China
- Publicly Traded?
- Yes
Source: Hong Kong Stock Exchangewww.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote
- Overseas Operations
- Yes
JD Health is ramping up to expand overseas, announcing plans in its 2020 annual report to acquire one or more offshore entities to be engaged in value-added telecom services and has already taken steps such as registering the domain jdhealth.hk and establishing a subsidiary in Hong Kong.Source: JD Health 2020 Annual Reportfiles.services/files/586/2021/0423/20210423164502_53203942_en.pdf
- US Sanctions
- No
- Military Affiliation in China
- No
Revenue
Source: JD Health 2020 Annual Reportfiles.services/files/586/2021/0423/20210423164502_53203942_en.pdf
Valuation
Valuation is reported as market capitalization. It was converted from HKD using the exchange rate from June 26, 2022 13:50:08.Source: Yahoo Financefinance.yahoo.com/quote/6618.HK/key-statistics
*Valuation is reported as market capitalization. It was converted from HKD using the exchange rate from June 26, 2022 13:50:08.
Employees
Source: JD Health IPO Filingfiles.services/files/586/2020/1126/20201126070002_75568423_en.pdf
JD Health is China’s largest online healthcare platform. It runs a supply chain of pharmaceutical and healthcare products and operates retail pharmacies and online healthcare services. In 2019, the company spun off from an online pharmacy under e-commerce giant JD.com. JD Health’s profitability helped it raise over $1.0 B in Series A funding in November 2019, earning it a $7.0 B valuation and making it the second-most valuable unicorn to emerge that year worldwide. An additional $830.0 M injection from Hillhouse Capital in August 2020 catapulted JD Health into its IPO later that year. In early December 2020, JD Health successfully listed on the Hong Kong Stock Exchange, raising $3.5 B in Hong Kong’s largest IPO of the year. It then set the record for the best first trading day on the Hong Kong Stock Exchange as its shares jumped 56%. The online pharmacy sector in China was worth about $57.0 B according to Deloitte, but profitability has been a struggle.
Source: JD Health Websiteir.jdhealth.com/en/index.phpSource: SCMPwww.scmp.com/tech/e-commerce/article/3044200/jds-health-care-unit-vaults-no-2-spot-new-unicorns-us7-billionSource: TechCrunchtechcrunch.com/2020/08/18/jd-coms-1-year-old-health-unicorn-to-get-830m-from-hillhouse/Source: CNBCwww.cnbc.com/2020/12/03/jd-health-hong-kong-ipo-raises-3point5-billion.htmlSource: Bloombergwww.bloomberg.com/news/articles/2020-12-08/jd-health-s-debut-is-the-best-by-a-mega-hong-kong-ipo-ecm-watch
-
- Name
- Ownership
-
- JD Jiankang
Source: Qichachawww.qcc.com/firm/he38af1072bc12d7ab7c7b5f3ff73750.html
- 67.49%
- JD Jiankang
- Xin Lijun (辛利军), Executive Director and CEO
- Liu Qiangdong (Richard) (刘强东), Chairman and Non-Executive Director
- Xu Lei (徐雷), Non-Executive Director
- Xu Ran (Sandy) (许冉), Non-Executive Director
- Zhang Pang (张雱), Non-Executive Director
- Li Yayun (李娅云), Non-Executive Director
- Yi Qingqing (易清清), Non-Executive Director
- Chen Xingyao (陈兴垚), Independent Non-Executive Director
- Li Ling (李玲), Independent Non-Executive Director
- Zhang Jiyu (张吉豫), Independent Non-Executive Director
- Huang Wenyi (黄文艺), Independent Non-Executive Director
- Cao Dong (曹冬), Chief Financial Officer
- Chiu Ming King (趙明璟), Company Secretary
Source: JD Health 2020 Annual Reportfiles.services/files/586/2021/0423/20210423164502_53203942_en.pdf
JD Health is ramping up to expand overseas, announcing plans in its 2020 annual report to acquire one or more offshore entities to be engaged in value-added telecom services and has already taken steps such as registering the domain jdhealth.hk and establishing a subsidiary in Hong Kong.
Source: JD Health 2020 Annual Reportfiles.services/files/586/2021/0423/20210423164502_53203942_en.pdf
JD Health Sanctions
While at this time it appears that this company is not the subject of any U.S. or other global sanctions, it is important to note that Chinese companies tend to have more opaque organizational structures than their Western peers. Chinese companies’ affiliated brands, operating units, and overseas subsidiaries are not always obvious or even identifiable. Given this, a Chinese company may not be the subject of sanctions, but one of its subsidiaries may be, thus making it difficult to accurately ascertain a company’s full sanctions status.
JD Health Reputational Disclosures
On April 10, 2017, JD Health was issued a warning letter by Chinese regulatory authorities for providing illegal guarantees and failing to disclose information in a timely manner.
Source: Qianlong (Finance)finance.qianlong.com/2017/0410/1586654.shtml
The latest news on JD Health from SupChina
Internet hospitals: A great idea that’s not working
China’s new “internet hospitals” are based on the promising idea of utilizing the power of the internet for medical care, but they have been incapable of being much more than online pharmacies.
JD Health has a great IPO in Hong Kong
A healthcare spin-off from China’s second-biggest ecommerce company did well in its first day of trading.
The latest news on JD Health from across the web
China Vows Further Curbs on ‘Disorderly Expansion’ by Tech Firms
China will take further steps to rein in internet companies, a senior cyberspace official said, citing the shared economy, online health care and smart delivery as areas of concern.
Chinese Tech Giant JD.com Founder Richard Liu to Step Back From Daily Business
The e-commerce company named its first president while facing tougher competition and a widening regulatory crackdown by Beijing.
China's health-care sector could be Beijing's next regulatory target, analysts say
China’s health-care sector will probably be the next to fall under scrutiny, analysts warn, as the country’s regulators crack down on everything from tech to education this year.
China Tech Shares Stage Rebound After Five-Week Selloff
Chinese technology stocks rallied in Hong Kong on Monday as bargain hunters pounced in the wake of the sector’s worst rout in months.
JD.com Healthcare Arm Raises $830m Series B Funding From Hillhouse
JD.com healthcare arm raises $830m Series B funding from Hillhouse
China’s Healthcare Companies Are the Next Big Thing. Where Investors Should Look.
China’s healthcare companies will get much bigger thanks to an aging population, bottlenecks in China’s state medical system, and prowess in drug research.
China’s online health platforms boom in wake of coronavirus
Demand for virtual consultations and drug sales driven by gaps in country’s healthcare coverage
JD Health shares close 56% higher on their market debut in Hong Kong
JD Health shares rallied throughout the day, hitting an intra-day high of 123.3 Hong Kong dollars — or as high as 75% from the offer price.
JD Health Shares Surge 28% in Hong Kong’s Gray Market Trading
JD Health International Inc. jumped in Hong Kong’s gray market trading, a sign that the city’s biggest IPO of the year is off to a good start.
How Alibaba and JD.com compare in their healthcare endeavors
China’s tech circle is shifting its attention to online healthcare this week as JD Health is set to go public in one of Hong Kong’s largest IPOs this year. Like Amazon, China’s e-commerce firms Alibaba and JD.com have been working to conquer the massive healthcare industry. The offerings are wide-ranging, reaching everything from around-the-clock delivery […]
JD Health IPO Will Set Hearts Racing
The record initial public offering of fintech giant Ant Group crashed before taking off. Another Chinese tech listing in Hong Kong should fare better.
JD Health may file $1 billion Hong Kong IPO by end-month · TechNode
JD Health is the latest JD.com affiliate preparing to go public in a recent spree amid mounting investor interest in healthtech.
JD Health Is Said to Pick Banks for $1 Billion Hong Kong IPO
JD Health has selected banks for its planned Hong Kong initial public offering, which it could file for as soon as this month, according to people familiar with the matter.
JD’s healthcare unit takes second spot in new global unicorns at a $7b valuation
It follows Uber’s self-driving unit, valued at US$7.3 billion, in the list of 142 new unicorns that emerged worldwide last year.
